Harvard Bioscience Inc Sample Contracts

EXHIBIT 2.1 PURCHASE AGREEMENT
Purchase Agreement • October 25th, 2000 • Harvard Bioscience Inc • Laboratory analytical instruments • New York
AutoNDA by SimpleDocs
AGREEMENT AND PLAN OF MERGER
Agreement and Plan of Merger • June 15th, 2001 • Harvard Bioscience Inc • Laboratory analytical instruments • Massachusetts
BROWN BROTHERS HARRIMAN & CO. AGENT FOR THE LENDERS REFERENCED HEREIN AND
Agreement • December 1st, 2000 • Harvard Bioscience Inc • Laboratory analytical instruments • Massachusetts
SECOND AMENDED AND RESTATED CREDIT AGREEMENT Dated as of March 29, 2013 among HARVARD BIOSCIENCE, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent and L/C Issuer, BROWN BROTHERS HARRIMAN & CO., and Each of the Other Lenders From...
Credit Agreement • April 3rd, 2013 • Harvard Bioscience Inc • Laboratory analytical instruments • Massachusetts

This SECOND AMENDED AND RESTATED CREDIT AGREEMENT (“Agreement”) is entered into as of March 29, 2013, among HARVARD BIOSCIENCE, INC., a Delaware corporation (the “Borrower”), BROWN BROTHERS HARRIMAN & CO. and each other lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent and L/C Issuer.

LEASE - of -
Lease • November 9th, 2000 • Harvard Bioscience Inc • Laboratory analytical instruments
Exhibit 1.1 6,422,450 SHARES HARVARD BIOSCIENCE, INC. COMMON STOCK, $.01 PAR VALUE UNDERWRITING AGREEMENT DATED: DECEMBER ____, 2000
Underwriting Agreement • December 5th, 2000 • Harvard Bioscience Inc • Laboratory analytical instruments • New York
HARVARD BIOSCIENCE, INC. UNAUDITED PRO FORMA FINANCIAL INFORMATION
Harvard Bioscience Inc • January 26th, 2018 • Laboratory analytical instruments

Harvard Bioscience, Inc. (the “Company”) has entered into a Purchase Agreement, dated January 22, 2018 (the “Purchase Agreement”), pursuant to which the Company sold substantially all of the assets of its wholly-owned subsidiary, Denville Scientific, Inc. (“Denville”) to Thomas Scientific, LLC (“Thomas Scientific”) for approximately $20 million, which includes a $3 million earn-out provision. At the completion of the sale, the Company received $17 million in cash from Thomas Scientific, including cash held in escrow.

By and Among
Securityholders' Agreement • October 25th, 2000 • Harvard Bioscience Inc • Laboratory analytical instruments
FINANCING AGREEMENT Dated as of January 31, 2018 by and among HARVARD BIOSCIENCE, INC., as Parent and as Borrowing Agent, PLYMOUTH Sub, Inc. (to be merged with and into Data Sciences International, Inc.) AND EACH OTHER SUBSIDIARY OF PARENT LISTED AS A...
Financing Agreement • February 2nd, 2018 • Harvard Bioscience Inc • Laboratory analytical instruments

Financing Agreement, dated as of January 31, 2018, by and among Harvard Bioscience, Inc., a Delaware corporation, a borrower (the "Parent" or the "Borrowing Agent"), Plymouth Sub, Inc., a Delaware corporation and directly wholly-owned subsidiary of the Parent, a borrower ("Merger Sub" or, prior to the consummation of the Acquisition (as defined herein), the "Initial Borrower"), which shall be merged with and into Data Sciences International, Inc., a Delaware corporation (the "Target" or, immediately upon consummation of the Acquisition, the "Surviving Borrower"), each of the other Borrowers (as defined herein) and Guarantors (as defined herein) from time to time party hereto, the lenders from time to time party hereto (each a "Lender" and collectively, the "Lenders"), Cerberus Business Finance, LLC, a Delaware limited liability company ("CBF"), as collateral agent and hypothecary representative for the Secured Parties (in such capacity, together with its successors and assigns in such

RECITALS
Form of Voting Agreement • July 19th, 2002 • Harvard Bioscience Inc • Laboratory analytical instruments • Delaware
HARVARD BIOSCIENCE, INC. AND REGISTRAR AND TRANSFER COMPANY AS RIGHTS AGENT SHAREHOLDER RIGHTS AGREEMENT DATED AS OF FEBRUARY 5, 2008
Shareholder Rights Agreement • February 8th, 2008 • Harvard Bioscience Inc • Laboratory analytical instruments • Delaware

Agreement, dated as of February 5, 2008, between Harvard Bioscience, Inc., a Delaware corporation (the “Company”), and Registrar and Transfer Company, a New Jersey corporation (the “Rights Agent”).

MADE BETWEEN
Harvard Bioscience Inc • November 9th, 2000 • Laboratory analytical instruments
HARVARD BIOSCIENCE, INC. EMPLOYMENT AGREEMENT
Release Agreement • November 1st, 2019 • Harvard Bioscience Inc • Laboratory analytical instruments • Massachusetts

This EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made as of the 31st day of October, 2019, between Harvard Bioscience, Inc., a Delaware corporation (the “Company”), and Yash Singh (“Executive”). For purposes of this Agreement the “Company” shall refer to the Company and any of its predecessors.

AutoNDA by SimpleDocs
PRODUCT DISTRIBUTION AGREEMENT BY AND BETWEEN HARVARD BIOSCIENCE, INC. AND HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC. DATED AS OF OCTOBER 31, 2013
Product Distribution Agreement • November 6th, 2013 • Harvard Bioscience Inc • Laboratory analytical instruments • Massachusetts

THIS PRODUCT DISTRIBUTION AGREEMENT dated as of October 31, 2013 (this “Agreement”), is entered into by and between HARVARD BIOSCIENCE, INC., a Delaware corporation (“HBIO”) and HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC., a Delaware corporation (“HART”) (each, a “Party” and, collectively, the “Parties”).

INTELLECTUAL PROPERTY MATTERS AGREEMENT BY AND BETWEEN HARVARD BIOSCIENCE, INC. and HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC. Dated as of October 31, 2013 INTELLECTUAL PROPERTY MATTERS AGREEMENT
Intellectual Property Matters Agreement • November 6th, 2013 • Harvard Bioscience Inc • Laboratory analytical instruments • Massachusetts

THIS INTELLECTUAL PROPERTY MATTERS AGREEMENT (this “Agreement”) is dated as of October 31, 2013, by and between Harvard Bioscience, Inc., a Delaware corporation (“HBIO”), and Harvard Apparatus Regenerative Technology, a Delaware corporation and a wholly owned subsidiary of HBIO (“HART”). HBIO and HART are each referred to herein as a “Party” and collectively as the “Parties.”

HARVARD BIOSCIENCE, INC. EMPLOYMENT AGREEMENT
Employment Agreement • May 27th, 2016 • Harvard Bioscience Inc • Laboratory analytical instruments • Massachusetts

This EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made as of the 26th day of May, 2016, between Harvard Bioscience, Inc., a Delaware corporation (the “Company”), and Yong Sun (“Executive”). For purposes of this Agreement the “Company” shall refer to the Company and any of its predecessors.

HARVARD BIOSCIENCE, INC. EMPLOYMENT AGREEMENT
Release Agreement • June 20th, 2023 • Harvard Bioscience Inc • Laboratory analytical instruments

This EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made as of the date of last signature below (the “Commencement Date”) between Harvard Bioscience, Inc., a Delaware corporation (the “Company”), and Jennifer Cote (“Executive”). For purposes of this Agreement the “Company” shall refer to the Company and any of its predecessors.

REVOLVING CREDIT LOAN AGREEMENT dated as of November 21, 2003 by and among
Revolving Credit Loan Agreement • March 15th, 2004 • Harvard Bioscience Inc • Laboratory analytical instruments • Massachusetts

REVOLVING CREDIT LOAN AGREEMENT dated as of November 21, 2003 by and among Harvard Bioscience, Inc., a Delaware corporation (the “Borrower”) and the Lenders from time to time party hereto, including Brown Brothers Harriman & Co. (both in its capacity as a “Lender” and in its capacity as “Agent” for itself and the other Lenders), and Fleet National Bank (as a “Lender” and, collectively with Brown Brothers Harriman & Co. the “Lenders”). Certain other terms used herein are defined in Section 2 (LIBOR Provisions) and in Section 9.

FIRST AMENDMENT TO FINANCING AGREEMENT
Financing Agreement • November 1st, 2018 • Harvard Bioscience Inc • Laboratory analytical instruments • New York

FIRST AMENDMENT, dated as of August 16, 2018 (this "Amendment"), to the Financing Agreement, dated as of January 31, 2018 (as the same may be amended, restated, supplemented or otherwise modified from time to time, including any replacement agreement therefor, the "Financing Agreement"), by and among Harvard Bioscience, Inc., a Delaware corporation (the "Parent" or the "Borrowing Agent"), each subsidiary of the Parent listed as a "Borrower" on the signature pages thereto (together with the Parent and each other Person that executes a joinder agreement and becomes a "Borrower" thereunder, each a "Borrower" and collectively, the "Borrowers"), the Guarantors (as defined therein) from time to time party thereto, the lenders from time to time party thereto (each a "Lender" and collectively, the "Lenders"), Cerberus Business Finance, LLC, a Delaware limited liability company, as collateral agent for the Lenders (in such capacity, together with its successors and assigns in such capacity, the

LIMITED CONSENT AND WAIVER
Consent and Waiver • March 17th, 2017 • Harvard Bioscience Inc • Laboratory analytical instruments • Massachusetts

This LIMITED CONSENT AND WAIVER (this “Limited Consent”) is dated as of November 1, 2016, and is effective as of October 26, 2016 and is made by and among HARVARD BIOSCIENCE, INC. (the “Borrower”), BANK OF AMERICA N.A., as Administrative Agent (“Agent”) L/C Issuer and Lender, and BROWN BROTHERS HARRIMAN & CO. (“BBH”).

SEPARATION AND RELEASE AGREEMENT
Separation and Release Agreement • July 8th, 2019 • Harvard Bioscience Inc • Laboratory analytical instruments

This Separation and Release Agreement (the “Release Agreement”) is entered into by Jeffrey Duchemin (the “Executive”) and Harvard Bioscience, Inc. (the “Company”) as of the date that the last party executing this Release Agreement executes the same as noted on the signature page hereto. This is the Release Agreement referenced in the Agreement between the Executive and the Company made as of August 26, 2013 (as amended or modified from time to time, the “Employment Agreement”).

Time is Money Join Law Insider Premium to draft better contracts faster.